NAD+ metabolism is a key modulator of bacterial respiratory epithelial infections

Abstract Lower respiratory tract infections caused by Streptococcus pneumoniae (Spn) are a leading cause of death globally. Here we investigate the bronchial epithelial cellular response to Spn infection on a transcriptomic, proteomic and metabolic level. We found the NAD+ salvage pathway to be dysr...

Full description

Bibliographic Details
Main Authors: Björn Klabunde, André Wesener, Wilhelm Bertrams, Isabell Beinborn, Nicole Paczia, Kristin Surmann, Sascha Blankenburg, Jochen Wilhelm, Javier Serrania, Kèvin Knoops, Eslam M. Elsayed, Katrin Laakmann, Anna Lena Jung, Andreas Kirschbaum, Sven Hammerschmidt, Belal Alshaar, Nicolas Gisch, Mobarak Abu Mraheil, Anke Becker, Uwe Völker, Evelyn Vollmeister, Birke J. Benedikter, Bernd Schmeck
Format: Article
Language:English
Published: Nature Portfolio 2023-10-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-41372-w
_version_ 1827710150395297792
author Björn Klabunde
André Wesener
Wilhelm Bertrams
Isabell Beinborn
Nicole Paczia
Kristin Surmann
Sascha Blankenburg
Jochen Wilhelm
Javier Serrania
Kèvin Knoops
Eslam M. Elsayed
Katrin Laakmann
Anna Lena Jung
Andreas Kirschbaum
Sven Hammerschmidt
Belal Alshaar
Nicolas Gisch
Mobarak Abu Mraheil
Anke Becker
Uwe Völker
Evelyn Vollmeister
Birke J. Benedikter
Bernd Schmeck
author_facet Björn Klabunde
André Wesener
Wilhelm Bertrams
Isabell Beinborn
Nicole Paczia
Kristin Surmann
Sascha Blankenburg
Jochen Wilhelm
Javier Serrania
Kèvin Knoops
Eslam M. Elsayed
Katrin Laakmann
Anna Lena Jung
Andreas Kirschbaum
Sven Hammerschmidt
Belal Alshaar
Nicolas Gisch
Mobarak Abu Mraheil
Anke Becker
Uwe Völker
Evelyn Vollmeister
Birke J. Benedikter
Bernd Schmeck
author_sort Björn Klabunde
collection DOAJ
description Abstract Lower respiratory tract infections caused by Streptococcus pneumoniae (Spn) are a leading cause of death globally. Here we investigate the bronchial epithelial cellular response to Spn infection on a transcriptomic, proteomic and metabolic level. We found the NAD+ salvage pathway to be dysregulated upon infection in a cell line model, primary human lung tissue and in vivo in rodents, leading to a reduced production of NAD+. Knockdown of NAD+ salvage enzymes (NAMPT, NMNAT1) increased bacterial replication. NAD+ treatment of Spn inhibited its growth while growth of other respiratory pathogens improved. Boosting NAD+ production increased NAD+ levels in immortalized and primary cells and decreased bacterial replication upon infection. NAD+ treatment of Spn dysregulated the bacterial metabolism and reduced intrabacterial ATP. Enhancing the bacterial ATP metabolism abolished the antibacterial effect of NAD+. Thus, we identified the NAD+ salvage pathway as an antibacterial pathway in Spn infections, predicting an antibacterial mechanism of NAD+.
first_indexed 2024-03-10T17:34:05Z
format Article
id doaj.art-f53e17d7ffee4a8b866fd16db80c5bb8
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-03-10T17:34:05Z
publishDate 2023-10-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-f53e17d7ffee4a8b866fd16db80c5bb82023-11-20T09:56:26ZengNature PortfolioNature Communications2041-17232023-10-0114111610.1038/s41467-023-41372-wNAD+ metabolism is a key modulator of bacterial respiratory epithelial infectionsBjörn Klabunde0André Wesener1Wilhelm Bertrams2Isabell Beinborn3Nicole Paczia4Kristin Surmann5Sascha Blankenburg6Jochen Wilhelm7Javier Serrania8Kèvin Knoops9Eslam M. Elsayed10Katrin Laakmann11Anna Lena Jung12Andreas Kirschbaum13Sven Hammerschmidt14Belal Alshaar15Nicolas Gisch16Mobarak Abu Mraheil17Anke Becker18Uwe Völker19Evelyn Vollmeister20Birke J. Benedikter21Bernd Schmeck22Institute for Lung Research, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Philipps-Universität MarburgInstitute for Lung Research, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Philipps-Universität MarburgInstitute for Lung Research, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Philipps-Universität MarburgInstitute for Lung Research, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Philipps-Universität MarburgCore Facility for Metabolomics and Small Molecule Mass Spectrometry, Max Planck Institute for Terrestrial MicrobiologyDepartment of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine GreifswaldDepartment of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine GreifswaldInstitute for Lung Health (ILH)Center for Synthetic Microbiology (SYNMIKRO), Philipps-Universität MarburgMicroscopy CORE Lab, Maastricht Multimodal Molecular Imaging Institute (M4I), Maastricht UniversityCenter for Synthetic Microbiology (SYNMIKRO), Philipps-Universität MarburgInstitute for Lung Research, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Philipps-Universität MarburgInstitute for Lung Research, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Philipps-Universität MarburgDepartment of Visceral, Thoracic and Vascular Surgery, University Hospital Gießen and Marburg (UKGM)Department of Molecular Genetics and Infection Biology, Interfaculty Institute for Genetics and Functional Genomics, Center for Functional Genomics of Microbes, University of GreifswaldDivision of Bioanalytical Chemistry, Priority Area Infections, Research Center Borstel, Leibniz Lung CenterDivision of Bioanalytical Chemistry, Priority Area Infections, Research Center Borstel, Leibniz Lung CenterInstitute for Medical Microbiology, Justus-Liebig Universität GiessenCenter for Synthetic Microbiology (SYNMIKRO), Philipps-Universität MarburgDepartment of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine GreifswaldInstitute for Lung Research, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Philipps-Universität MarburgInstitute for Lung Research, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Philipps-Universität MarburgInstitute for Lung Research, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Philipps-Universität MarburgAbstract Lower respiratory tract infections caused by Streptococcus pneumoniae (Spn) are a leading cause of death globally. Here we investigate the bronchial epithelial cellular response to Spn infection on a transcriptomic, proteomic and metabolic level. We found the NAD+ salvage pathway to be dysregulated upon infection in a cell line model, primary human lung tissue and in vivo in rodents, leading to a reduced production of NAD+. Knockdown of NAD+ salvage enzymes (NAMPT, NMNAT1) increased bacterial replication. NAD+ treatment of Spn inhibited its growth while growth of other respiratory pathogens improved. Boosting NAD+ production increased NAD+ levels in immortalized and primary cells and decreased bacterial replication upon infection. NAD+ treatment of Spn dysregulated the bacterial metabolism and reduced intrabacterial ATP. Enhancing the bacterial ATP metabolism abolished the antibacterial effect of NAD+. Thus, we identified the NAD+ salvage pathway as an antibacterial pathway in Spn infections, predicting an antibacterial mechanism of NAD+.https://doi.org/10.1038/s41467-023-41372-w
spellingShingle Björn Klabunde
André Wesener
Wilhelm Bertrams
Isabell Beinborn
Nicole Paczia
Kristin Surmann
Sascha Blankenburg
Jochen Wilhelm
Javier Serrania
Kèvin Knoops
Eslam M. Elsayed
Katrin Laakmann
Anna Lena Jung
Andreas Kirschbaum
Sven Hammerschmidt
Belal Alshaar
Nicolas Gisch
Mobarak Abu Mraheil
Anke Becker
Uwe Völker
Evelyn Vollmeister
Birke J. Benedikter
Bernd Schmeck
NAD+ metabolism is a key modulator of bacterial respiratory epithelial infections
Nature Communications
title NAD+ metabolism is a key modulator of bacterial respiratory epithelial infections
title_full NAD+ metabolism is a key modulator of bacterial respiratory epithelial infections
title_fullStr NAD+ metabolism is a key modulator of bacterial respiratory epithelial infections
title_full_unstemmed NAD+ metabolism is a key modulator of bacterial respiratory epithelial infections
title_short NAD+ metabolism is a key modulator of bacterial respiratory epithelial infections
title_sort nad metabolism is a key modulator of bacterial respiratory epithelial infections
url https://doi.org/10.1038/s41467-023-41372-w
work_keys_str_mv AT bjornklabunde nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT andrewesener nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT wilhelmbertrams nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT isabellbeinborn nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT nicolepaczia nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT kristinsurmann nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT saschablankenburg nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT jochenwilhelm nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT javierserrania nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT kevinknoops nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT eslammelsayed nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT katrinlaakmann nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT annalenajung nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT andreaskirschbaum nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT svenhammerschmidt nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT belalalshaar nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT nicolasgisch nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT mobarakabumraheil nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT ankebecker nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT uwevolker nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT evelynvollmeister nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT birkejbenedikter nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections
AT berndschmeck nadmetabolismisakeymodulatorofbacterialrespiratoryepithelialinfections